Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 134

1.

Activation of Th lymphocytes alters pattern expression and cellular location of VIP receptors in healthy donors and early arthritis patients.

Villanueva-Romero R, Gutiérrez-Cañas I, Carrión M, González-Álvaro I, Rodríguez-Frade JM, Mellado M, Martínez C, Gomariz RP, Juarranz Y.

Sci Rep. 2019 May 14;9(1):7383. doi: 10.1038/s41598-019-43717-2.

2.

The comparative responsiveness of Hospital Universitario Princesa Index and other composite indices for assessing rheumatoid arthritis activity.

González-Álvaro I, Castrejón I, Carmona L; ACT-RAY, PROAR and EMECAR study groups.

PLoS One. 2019 Apr 10;14(4):e0214717. doi: 10.1371/journal.pone.0214717. eCollection 2019.

3.

Reproducibility of Metacarpal Bone Mineral Density Measurements Obtained by Dual-Energy X-Ray Absorptiometry in Healthy Volunteers and Patients With Early Arthritis.

Llorente I, Merino L, Escolano E, Quintanilla DM, García-Vadillo JA, González-Álvaro I, Castañeda S.

J Clin Densitom. 2019 Feb 27. pii: S1094-6950(18)30254-3. doi: 10.1016/j.jocd.2019.02.006. [Epub ahead of print]

PMID:
30910402
4.

Rituximab induces a lasting, non-cumulative remodelling of the B-cell compartment.

López J, Merino L, Piris L, Herrera FS, Llorente I, Humbría A, Ortiz AM, Velasco T, García-Vicuña R, Castañeda S, González Álvaro I, Muñoz-Calleja C.

Clin Exp Rheumatol. 2018 Dec 19. [Epub ahead of print]

PMID:
30620289
5.

Meta-analysis of Immunochip data of four autoimmune diseases reveals novel single-disease and cross-phenotype associations.

Márquez A, Kerick M, Zhernakova A, Gutierrez-Achury J, Chen WM, Onengut-Gumuscu S, González-Álvaro I, Rodriguez-Rodriguez L, Rios-Fernández R, González-Gay MA; Coeliac Disease Immunochip Consortium; Rheumatoid Arthritis Consortium International for Immunochip (RACI); International Scleroderma Group; Type 1 Diabetes Genetics Consortium, Mayes MD, Raychaudhuri S, Rich SS, Wijmenga C, Martín J.

Genome Med. 2018 Dec 20;10(1):97. doi: 10.1186/s13073-018-0604-8.

6.

Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis.

Aterido A, Cañete JD, Tornero J, Ferrándiz C, Pinto JA, Gratacós J, Queiró R, Montilla C, Torre-Alonso JC, Pérez-Venegas JJ, Fernández Nebro A, Muñoz-Fernández S, González CM, Roig D, Zarco P, Erra A, Rodríguez J, Castañeda S, Rubio E, Salvador G, Díaz-Torné C, Blanco R, Willisch Domínguez A, Mosquera JA, Vela P, Sánchez-Fernández SA, Corominas H, Ramírez J, de la Cueva P, Fonseca E, Fernández E, Puig L, Dauden E, Sánchez-Carazo JL, López-Estebaranz JL, Moreno D, Vanaclocha F, Herrera E, Blanco F, Fernández-Gutiérrez B, González A, Pérez-García C, Alperi-López M, Olivé Marques A, Martínez-Taboada V, González-Álvaro I, Sanmartí R, Tomás Roura C, García-Montero AC, Bonàs-Guarch S, Mercader JM, Torrents D, Codó L, Gelpí JL, López-Corbeto M, Pluma A, López-Lasanta M, Tortosa R, Palau N, Absher D, Myers R, Marsal S, Julià A.

Ann Rheum Dis. 2019 Mar;78(3). pii: e214158. doi: 10.1136/annrheumdis-2018-214158. Epub 2018 Dec 14.

PMID:
30552173
7.

Specific Association of HLA-DRB1*03 With Anti-Carbamylated Protein Antibodies in Patients With Rheumatoid Arthritis.

Regueiro C, Rodriguez-Rodriguez L, Triguero-Martinez A, Nuño L, Castaño-Nuñez AL, Villalva A, Perez-Pampin E, Lopez-Golan Y, Abasolo L, Ortiz AM, Herranz E, Pascual-Salcedo D, Martínez-Feito A, Boveda MD, Gomez-Reino JJ, Martín J, Gonzalez-Escribano MF, Fernandez-Gutierrez B, Balsa A, Gonzalez-Alvaro I, Gonzalez A.

Arthritis Rheumatol. 2019 Mar;71(3):331-339. doi: 10.1002/art.40738. Epub 2019 Jan 28.

PMID:
30277011
8.

Identification of a 3'-Untranslated Genetic Variant of RARB Associated With Carotid Intima-Media Thickness in Rheumatoid Arthritis: A Genome-Wide Association Study.

López-Mejías R, Carmona FD, Genre F, Remuzgo-Martínez S, González-Juanatey C, Corrales A, Vicente EF, Pulito-Cueto V, Miranda-Filloy JA, Ramírez Huaranga MA, Blanco R, Robustillo-Villarino M, Rodríguez-Carrio J, Alperi-López M, Alegre-Sancho JJ, Mijares V, Lera-Gómez L, Pérez-Pampín E, González A, Ortega-Castro R, López-Pedrera C, García Vivar ML, Gómez-Arango C, Raya E, Narvaez J, Balsa A, López-Longo FJ, Carreira P, González-Álvaro I, Rodríguez-Rodríguez L, Fernández-Gutiérrez B, Ferraz-Amaro I, Gualillo O, Castañeda S, Martín J, Llorca J, González-Gay MA.

Arthritis Rheumatol. 2019 Mar;71(3):351-360. doi: 10.1002/art.40734. Epub 2019 Jan 18.

PMID:
30251476
9.

Association of high titers of anti-carbamylated protein antibodies with decreased bone mineral density in early arthritis patients.

Regueiro C, Ortiz AM, Boveda MD, Castañeda S, Gonzalez-Alvaro I, Gonzalez A.

PLoS One. 2018 Aug 17;13(8):e0202583. doi: 10.1371/journal.pone.0202583. eCollection 2018.

10.

Experience With the Use of Rituximab for the Treatment of Rheumatoid Arthritis in a Tertiary Hospital in Spain: RITAR Study.

Cañamares-Orbis I, Merino L, López J, Llorente I, García-Vadillo A, Ramirez E, López-Bote JP, Benedí J, Muñoz-Calleja C, Álvaro-Gracia JM, Castañeda S, González-Álvaro I.

J Clin Rheumatol. 2018 Jul 19. doi: 10.1097/RHU.0000000000000845. [Epub ahead of print]

11.

Association of a rare variant of the TNFSF13B gene with susceptibility to Rheumatoid Arthritis and Systemic Lupus Erythematosus.

González-Serna D, Ortiz-Fernández L, Vargas S, García A, Raya E, Fernández-Gutierrez B, López-Longo FJ, Balsa A, González-Álvaro I, Narvaez J, Gómez-Vaquero C, Sabio JM, García-Portales R, González-Escribano MF, Tolosa C, Carreira P, Kiemeney L, Coenen MJH, Witte T, Schneider M, González-Gay MÁ, Martín J.

Sci Rep. 2018 May 29;8(1):8195. doi: 10.1038/s41598-018-26573-4.

12.

Replication study of polymorphisms associated with response to methotrexate in patients with rheumatoid arthritis.

López-Rodríguez R, Ferreiro-Iglesias A, Lima A, Bernardes M, Pawlik A, Paradowska-Gorycka A, Świerkot J, Slezak R, Dolžan V, González-Álvaro I, Narváez J, Cáliz R, Pérez-Pampín E, Mera-Varela A, Vidal-Bralo L, Acuña Ochoa JG, Conde C, Gómez-Reino JJ, González A.

Sci Rep. 2018 May 9;8(1):7342. doi: 10.1038/s41598-018-25634-y.

13.

Evaluation of a clinical pharmacogenetics model to predict methotrexate response in patients with rheumatoid arthritis.

López-Rodríguez R, Ferreiro-Iglesias A, Lima A, Bernardes M, Pawlik A, Paradowska-Gorycka A, Świerkot J, Slezak R, Gonzalez-Alvaro I, Narvaez J, Pérez-Pampín E, Mera-Varela A, Vidal-Bralo L, Acuña-Ochoa JG, Conde C, Gonzalez A.

Pharmacogenomics J. 2018 Jul;18(4):539-545. doi: 10.1038/s41397-018-0017-5. Epub 2018 Mar 8.

PMID:
29520081
14.

Methotrexate limits inflammation through an A20-dependent cross-tolerance mechanism.

Municio C, Dominguez-Soto Á, Fuentelsaz-Romero S, Lamana A, Montes N, Cuevas VD, Campos RG, Pablos JL, González-Álvaro I, Puig-Kröger A.

Ann Rheum Dis. 2018 May;77(5):752-759. doi: 10.1136/annrheumdis-2017-212537. Epub 2018 Feb 3.

15.

Vasoactive intestinal peptide gene polymorphisms, associated with its serum levels, predict treatment requirements in early rheumatoid arthritis.

Seoane IV, Martínez C, García-Vicuña R, Ortiz AM, Juarranz Y, Talayero VC, González-Álvaro I, Gomariz RP, Lamana A.

Sci Rep. 2018 Feb 1;8(1):2035. doi: 10.1038/s41598-018-20400-6.

16.

REDOSER project: optimising biological therapy dose for rheumatoid arthritis and spondyloarthritis patients.

González-Álvaro I, Blasco AJ, Lázaro P, Sánchez-Piedra C, Almodovar R, Bachiller-Corral J, Balsa A, Caliz R, Candelas G, Fernández-Carballido C, García-Aparicio A, García-Magallón B, García-Vicuña R, Gómez-Centeno A, Ortiz AM, Sanmartí R, Sanz J, Tejera B.

Heliyon. 2017 Nov 14;3(11):e00452. doi: 10.1016/j.heliyon.2017.e00452. eCollection 2017 Nov.

17.

Are rheumatologists adhering to the concepts window of opportunity and treat-to-target? Earlier and more intense disease-modifying anti-rheumatic drug treatment over time in patients with early arthritis in the PEARL study.

Toledano E, Ortiz AM, Ivorra-Cortes J, Montes N, Beltran A, Rodríguez-Rodriguez L, Carmona L, González-Álvaro I.

Clin Exp Rheumatol. 2018 May-Jun;36(3):382-388. Epub 2017 Nov 28.

PMID:
29185958
18.

[Medullar thoracic compression by tophaceous gout: presentation of a case and review of the literature].

Arevalo-Saenz A, Gonzalez-Alvaro I, Pulido-Rivas P, Vicente E, Garcia E, Castaneda S, Ocon E, Gomez-Leon N, Sola RG.

Rev Neurol. 2017 Oct 16;65(8):368-372. Review. Spanish.

19.

Value of Measuring Anti-Carbamylated Protein Antibodies for Classification on Early Arthritis Patients.

Regueiro C, Nuño L, Ortiz AM, Peiteado D, Villalba A, Pascual-Salcedo D, Martínez-Feito A, González-Alvaro I, Balsa A, González A.

Sci Rep. 2017 Sep 20;7(1):12023. doi: 10.1038/s41598-017-09657-5.

20.

Development and validation of a multivariate predictive model for rheumatoid arthritis mortality using a machine learning approach.

Lezcano-Valverde JM, Salazar F, León L, Toledano E, Jover JA, Fernandez-Gutierrez B, Soudah E, González-Álvaro I, Abasolo L, Rodriguez-Rodriguez L.

Sci Rep. 2017 Aug 31;7(1):10189. doi: 10.1038/s41598-017-10558-w.

21.

Severity indices in rheumatoid arthritis: A systematic review.

Toledano E, García de Yébenes MJ, González-Álvaro I, Carmona L.

Reumatol Clin. 2019 May - Jun;15(3):146-151. doi: 10.1016/j.reuma.2017.07.004. Epub 2017 Aug 12. English, Spanish.

23.

Novelties in the therapeutic scene of rheumatoid arthritis.

Castañeda S, González-Álvaro I.

Reumatol Clin. 2017 Mar - Apr;13(2):63-65. doi: 10.1016/j.reuma.2017.02.001. English, Spanish. No abstract available.

24.

mRNA profiling identifies low levels of phosphatases dual‐specific phosphatase‐7 (DUSP7) and cell division cycle‐25B (CDC25B) in patients with early arthritis.

Castro-Sánchez P, Ramirez-Munoz R, Lamana A, Ortiz A, González-Álvaro I, Roda-Navarro P.

Clin Exp Immunol. 2017 Jul;189(1):113-119. doi: 10.1111/cei.12953. Epub 2017 Mar 28. Erratum in: Clin Exp Immunol. 2018 Feb;191(2):252.

25.

Anti-citrullinated protein antibodies are associated with decreased bone mineral density: baseline data from a register of early arthritis patients.

Llorente I, Merino L, Ortiz AM, Escolano E, González-Ortega S, García-Vicuña R, García-Vadillo JA, Castañeda S, González-Álvaro I.

Rheumatol Int. 2017 May;37(5):799-806. doi: 10.1007/s00296-017-3674-9. Epub 2017 Feb 27.

26.

Influence of coronary artery disease and subclinical atherosclerosis related polymorphisms on the risk of atherosclerosis in rheumatoid arthritis.

López-Mejías R, Corrales A, Vicente E, Robustillo-Villarino M, González-Juanatey C, Llorca J, Genre F, Remuzgo-Martínez S, Dierssen-Sotos T, Miranda-Filloy JA, Huaranga MA, Pina T, Blanco R, Alegre-Sancho JJ, Raya E, Mijares V, Ubilla B, Ferraz-Amaro I, Gómez-Vaquero C, Balsa A, López-Longo FJ, Carreira P, González-Álvaro I, Ocejo-Vinyals JG, Rodríguez-Rodríguez L, Fernández-Gutiérrez B, Castañeda S, Martín J, González-Gay MA.

Sci Rep. 2017 Jan 6;7:40303. doi: 10.1038/srep40303.

27.

Impact of genetic variants of ATP binding cassette B1, AICAR transformylase/IMP cyclohydrolase, folyl-polyglutamatesynthetase, and methylenetetrahydrofolatereductase on methotrexate toxicity.

Sala-Icardo L, Lamana A, Ortiz AM, García Lorenzo E, Moreno Fresneda P, García-Vicuña R, González-Álvaro I.

Reumatol Clin. 2017 Nov - Dec;13(6):318-325. doi: 10.1016/j.reuma.2016.08.006. Epub 2016 Oct 15. English, Spanish.

28.

Influence of patient personality in the treatment of rheumatoid arthritis.

Leon L, Redondo M, Garcia-Vadillo A, Perez-Nieto MA, Rodriguez-Rodriguez L, Jover JA, Gonzalez-Alvaro I, Abasolo L.

Rheumatol Int. 2016 Nov;36(11):1549-1555. Epub 2016 Sep 10.

PMID:
27614619
29.

Urine metabolome profiling of immune-mediated inflammatory diseases.

Alonso A, Julià A, Vinaixa M, Domènech E, Fernández-Nebro A, Cañete JD, Ferrándiz C, Tornero J, Gisbert JP, Nos P, Casbas AG, Puig L, González-Álvaro I, Pinto-Tasende JA, Blanco R, Rodríguez MA, Beltran A, Correig X, Marsal S; IMID Consortium.

BMC Med. 2016 Sep 8;14(1):133. doi: 10.1186/s12916-016-0681-8.

30.

Cut-Offs and Response Criteria for the Hospital Universitario La Princesa Index (HUPI) and Their Comparison to Widely-Used Indices of Disease Activity in Rheumatoid Arthritis.

González-Álvaro I, Castrejón I, Ortiz AM, Toledano E, Castañeda S, García-Vadillo A, Carmona L; EMECAR Study Group.

PLoS One. 2016 Sep 7;11(9):e0161727. doi: 10.1371/journal.pone.0161727. eCollection 2016.

31.

Influence of elevated-CRP level-related polymorphisms in non-rheumatic Caucasians on the risk of subclinical atherosclerosis and cardiovascular disease in rheumatoid arthritis.

López-Mejías R, Genre F, Remuzgo-Martínez S, González-Juanatey C, Robustillo-Villarino M, Llorca J, Corrales A, Vicente E, Miranda-Filloy JA, Magro C, Tejera-Segura B, Ramírez Huaranga MA, Pina T, Blanco R, Alegre-Sancho JJ, Raya E, Mijares V, Ubilla B, Mínguez Sánchez MD, Gómez-Vaquero C, Balsa A, Pascual-Salcedo D, López-Longo FJ, Carreira P, González-Álvaro I, Rodríguez-Rodríguez L, Fernández-Gutiérrez B, Ferraz-Amaro I, Castañeda S, Martín J, González-Gay MA.

Sci Rep. 2016 Aug 18;6:31979. doi: 10.1038/srep31979.

32.

Comparative analysis of EV isolation procedures for miRNAs detection in serum samples.

Andreu Z, Rivas E, Sanguino-Pascual A, Lamana A, Marazuela M, González-Alvaro I, Sánchez-Madrid F, de la Fuente H, Yáñez-Mó M.

J Extracell Vesicles. 2016 Jun 20;5:31655. doi: 10.3402/jev.v5.31655. eCollection 2016.

33.

A combined large-scale meta-analysis identifies COG6 as a novel shared risk locus for rheumatoid arthritis and systemic lupus erythematosus.

Márquez A, Vidal-Bralo L, Rodríguez-Rodríguez L, González-Gay MA, Balsa A, González-Álvaro I, Carreira P, Ortego-Centeno N, Ayala-Gutiérrez MM, García-Hernández FJ, González-Escribano MF, Sabio JM, Tolosa C, Suárez A, González A, Padyukov L, Worthington J, Vyse T, Alarcón-Riquelme ME, Martín J.

Ann Rheum Dis. 2017 Jan;76(1):286-294. doi: 10.1136/annrheumdis-2016-209436. Epub 2016 May 18.

PMID:
27193031
34.

Independent Candidate Serum Protein Biomarkers of Response to Adalimumab and to Infliximab in Rheumatoid Arthritis: An Exploratory Study.

Ortea I, Roschitzki B, López-Rodríguez R, Tomero EG, Ovalles JG, López-Longo J, de la Torre I, González-Alvaro I, Gómez-Reino JJ, González A.

PLoS One. 2016 Apr 6;11(4):e0153140. doi: 10.1371/journal.pone.0153140. eCollection 2016.

35.

Methotrexate selectively targets human proinflammatory macrophages through a thymidylate synthase/p53 axis.

Municio C, Soler Palacios B, Estrada-Capetillo L, Benguria A, Dopazo A, García-Lorenzo E, Fernández-Arroyo S, Joven J, Miranda-Carús ME, González-Álvaro I, Puig-Kröger A.

Ann Rheum Dis. 2016 Dec;75(12):2157-2165. doi: 10.1136/annrheumdis-2015-208736. Epub 2016 Feb 26.

PMID:
26920997
36.

Clinical Relevance of VPAC1 Receptor Expression in Early Arthritis: Association with IL-6 and Disease Activity.

Seoane IV, Ortiz AM, Piris L, Lamana A, Juarranz Y, García-Vicuña R, González-Álvaro I, Gomariz RP, Martínez C.

PLoS One. 2016 Feb 16;11(2):e0149141. doi: 10.1371/journal.pone.0149141. eCollection 2016.

37.

VIP and CRF reduce ADAMTS expression and function in osteoarthritis synovial fibroblasts.

Pérez-García S, Carrión M, Gutiérrez-Cañas I, González-Álvaro I, Gomariz RP, Juarranz Y.

J Cell Mol Med. 2016 Apr;20(4):678-87. doi: 10.1111/jcmm.12777. Epub 2016 Jan 28.

38.

Identification of IRX1 as a Risk Locus for Rheumatoid Factor Positivity in Rheumatoid Arthritis in a Genome-Wide Association Study.

Julià A, Blanco F, Fernández-Gutierrez B, González A, Cañete JD, Maymó J, Alperi-López M, Olivè A, Corominas H, Martínez-Taboada V, González-Álvaro I, Fernandez-Nebro A, Erra A, Sánchez-Fernández S, Alonso A, López-Lasanta M, Tortosa R, Codó L, Lluis Gelpi J, García-Montero AC, Bertranpetit J, Absher D, Myers RM, Tornero J, Marsal S.

Arthritis Rheumatol. 2016 Jun;68(6):1384-91. doi: 10.1002/art.39591.

39.

The Minor Allele of rs7574865 in the STAT4 Gene Is Associated with Increased mRNA and Protein Expression.

Lamana A, López-Santalla M, Castillo-González R, Ortiz AM, Martín J, García-Vicuña R, González-Álvaro I.

PLoS One. 2015 Nov 16;10(11):e0142683. doi: 10.1371/journal.pone.0142683. eCollection 2015.

40.

PTGER4 gene variant rs76523431 is a candidate risk factor for radiological joint damage in rheumatoid arthritis patients: a genetic study of six cohorts.

Rodriguez-Rodriguez L, Ivorra-Cortes J, Carmona FD, Martín J, Balsa A, van Steenbergen HW, van der Helm-van Mil AH, González-Álvaro I, Fernandez-Gutiérrez B.

Arthritis Res Ther. 2015 Nov 5;17:306. doi: 10.1186/s13075-015-0830-z.

41.

Variation at interleukin-6 receptor gene is associated to joint damage in rheumatoid arthritis.

Lopez-Lasanta M, Julià A, Maymó J, Fernández-Gutierrez B, Ureña-Garnica I, Blanco FJ, Cañete JD, Alperi-López M, Olivè A, Corominas H, Tornero J, Erra A, Almirall M, Palau N, Ortiz A, Avila G, Rodriguez-Rodriguez L, Alonso A, Tortosa R, Gonzalez-Alvaro I, Marsal S.

Arthritis Res Ther. 2015 Sep 4;17:242. doi: 10.1186/s13075-015-0737-8.

42.

[Rheumatoid arthritis at present].

González-Álvaro I, García-Vicuña R.

Med Clin (Barc). 2016 Feb 5;146(3):112-4. doi: 10.1016/j.medcli.2015.06.004. Epub 2015 Jul 27. Spanish. No abstract available.

PMID:
26228258
43.

2014 update of the Consensus Statement of the Spanish Society of Rheumatology on the use of biological therapies in rheumatoid arthritis.

Sanmartí R, García-Rodríguez S, Álvaro-Gracia JM, Andreu JL, Balsa A, Cáliz R, Fernández-Nebro A, Ferraz-Amaro I, Gómez-Reino JJ, González-Álvaro I, Martín-Mola E, Martínez-Taboada VM, Ortiz AM, Tornero J, Marsal S, Moreno-Muelas JV.

Reumatol Clin. 2015 Sep-Oct;11(5):279-94. doi: 10.1016/j.reuma.2015.05.001. Epub 2015 Jun 6. English, Spanish.

44.

Variation at FCGR2A and functionally related genes is associated with the response to anti-TNF therapy in rheumatoid arthritis.

Avila-Pedretti G, Tornero J, Fernández-Nebro A, Blanco F, González-Alvaro I, Cañete JD, Maymó J, Alperiz M, Fernández-Gutiérrez B, Olivé A, Corominas H, Erra A, Aterido A, López Lasanta M, Tortosa R, Julià A, Marsal S.

PLoS One. 2015 Apr 7;10(4):e0122088. doi: 10.1371/journal.pone.0122088. eCollection 2015.

45.

Vasoactive Intestinal Peptide in Early Spondyloarthritis: Low Serum Levels as a Potential Biomarker for Disease Severity.

Seoane IV, Tomero E, Martínez C, Garcia-Vicuña R, Juarranz Y, Lamana A, Ocón E, Ortiz AM, Gómez-León N, González-Álvaro I, Gomariz RP.

J Mol Neurosci. 2015 Jul;56(3):577-84. doi: 10.1007/s12031-015-0517-6. Epub 2015 Feb 25.

46.

Consensus statement on a framework for the management of comorbidity and extra-articular manifestations in rheumatoid arthritis.

Loza E, Lajas C, Andreu JL, Balsa A, González-Álvaro I, Illera O, Jover JÁ, Mateo I, Orte J, Rivera J, Rodríguez Heredia JM, Romero F, Martínez-López JA, Ortiz AM, Toledano E, Villaverde V, Carmona L, Castañeda S.

Rheumatol Int. 2015 Mar;35(3):445-58. doi: 10.1007/s00296-014-3196-7. Epub 2014 Dec 28. Review.

PMID:
25543267
47.

Spanish Rheumatology Society and Hospital Pharmacy Society Consensus on recommendations for biologics optimization in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis.

González-Álvaro I, Martínez-Fernández C, Dorantes-Calderón B, García-Vicuña R, Hernández-Cruz B, Herrero-Ambrosio A, Ibarra-Barrueta O, Martín-Mola E, Monte-Boquet E, Morell-Baladrón A, Sanmartí R, Sanz-Sanz J, de Toro-Santos FJ, Vela P, Román Ivorra JA, Poveda-Andrés JL, Muñoz-Fernández S; Spanish Rheumatology Society; Spanish Rheumatology Society.

Rheumatology (Oxford). 2015 Jul;54(7):1200-9. doi: 10.1093/rheumatology/keu461. Epub 2014 Dec 19.

48.

The pathogenic Th profile of human activated memory Th cells in early rheumatoid arthritis can be modulated by VIP.

Jimeno R, Gomariz RP, Garín M, Gutiérrez-Cañas I, González-Álvaro I, Carrión M, Galindo M, Leceta J, Juarranz Y.

J Mol Med (Berl). 2015 Apr;93(4):457-67. doi: 10.1007/s00109-014-1232-4. Epub 2014 Nov 28.

49.

Macrophages from the synovium of active rheumatoid arthritis exhibit an activin A-dependent pro-inflammatory profile.

Soler Palacios B, Estrada-Capetillo L, Izquierdo E, Criado G, Nieto C, Municio C, González-Alvaro I, Sánchez-Mateos P, Pablos JL, Corbí AL, Puig-Kröger A.

J Pathol. 2015 Feb;235(3):515-26. doi: 10.1002/path.4466. Epub 2014 Dec 18.

PMID:
25319955
50.

Lack of replication of interactions between polymorphisms in rheumatoid arthritis susceptibility: case-control study.

Ferreiro-Iglesias A, Calaza M, Perez-Pampin E, Lopez Longo FJ, Marenco JL, Blanco FJ, Narvaez J, Navarro F, Cañete JD, de la Serna AR, Gonzalez-Alvaro I, Herrero-Beaumont G, Pablos JL, Balsa A, Fernandez-Gutierrez B, Caliz R, Gomez-Reino JJ, Gonzalez A.

Arthritis Res Ther. 2014 Sep 27;16(5):436. doi: 10.1186/s13075-014-0436-x.

Supplemental Content

Loading ...
Support Center